JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chintala, M. S.
Right arrow Articles by Chiu, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chintala, M. S.
Right arrow Articles by Chiu, P. J.

Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats

MS Chintala, V Bernardino and PJ Chiu

Schering-Plough Research Institute, Kenilworth, New Jersey.

Platelets have been implicated in the pathophysiology of ischemia- reperfusion injury. In this study, antiplatelet effects of cyclic GMP (cGMP)- and cyclic AMP (cAMP)-mediated agents were evaluated in renal ischemia in pentobarbital-anesthetized rats. Renal ischemia was induced by unilateral occlusion of the left renal artery (40 min) followed by reperfusion (30 min) with the contralateral kidney serving as control. 111Indium-labeled platelets, drugs or vehicle were administered 30 min before induction of renal ischemia. Occlusion of the left renal artery for 20, 40 or 60 min resulted in a 100, 300 and 600% increase (over contralateral right kidney) in the platelet-associated 111indium activity in the ischemic kidney. In all subsequent studies the kidney was occluded for 40 min to test the antiplatelet activity of individual agents. 8-Br-cGMP (0.1 and 0.3 mg/kg/min i.v.), zaprinast (0.1 mg/kg/min i.v.) and sodium nitroprusside (0.003 and 0.01 mg/kg/min i.v.) significantly attenuated platelet accumulation in renal ischemia, whereas 8-Br-cAMP (0.3 mg/kg/min i.v.) or milrinone (0.1 mg/kg i.v. bolus, plus 0.01 mg/kg/min) did not. Minoxidil (0.01 and 0.03 mg/kg/min i.v.), a vasodilator which produced equihypotensive effects as the cGMP- mediated agents, and milrinone failed to prevent platelet accumulation. These results demonstrate that modulation of the platelet function by cGMP agents can be dissociated from their blood pressure lowering effects. cGMP is known to inhibit both platelet adhesion and aggregation, whereas cAMP is only active against aggregation. The present findings provide further evidence that cGMP-mediated drugs may afford effective antiplatelet action in an in vivo model of ischemia- reperfusion injury.

Volume 271, Issue 3, pp. 1203-1208, 12/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Marcondes, M. H. M. Cardoso, R. P. Morganti, S. M. Thomazzi, S. Lilla, F. Murad, G. De Nucci, and E. Antunes
Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: A role for {alpha}-actinin nitration
PNAS, February 28, 2006; 103(9): 3434 - 3439.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Xu, Y. Huo, M.-C. Toufektsian, S. I. Ramos, Y. Ma, A. D. Tejani, B. A. French, and Z. Yang
Activated platelets contribute importantly to myocardial reperfusion injury
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H692 - H699.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Nishijima, J. Kiryu, A. Tsujikawa, M. Honjo, A. Nonaka, K. Yamashiro, H. Kamizuru, Y. Ieki, H. Tanihara, Y. Honda, et al.
Inhibitory Effects of Antithrombin III on Interactions between Blood Cells and Endothelial Cells during Retinal Ischemia-Reperfusion Injury
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 332 - 341.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Nishijima, J. Kiryu, A. Tsujikawa, M. Honjo, A. Nonaka, K. Yamashiro, H. Tanihara, S. J. Tojo, Y. Ogura, and Y. Honda
In Vivo Evaluation of Platelet-Endothelial Interactions after Transient Retinal Ischemia
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2102 - 2109.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Massberg, G. Enders, F. C. d. M. Matos, L. I. D. Tomic, R. Leiderer, S. Eisenmenger, K. Messmer, and F. Krombach
Fibrinogen Deposition at the Postischemic Vessel Wall Promotes Platelet Adhesion During Ischemia-Reperfusion In Vivo
Blood, December 1, 1999; 94(11): 3829 - 3838.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Hillinger, R. A. Schmid, P. Sandera, U. Stammberger, D. Schneiter, G. Schoedon, and W. Weder
8-Br-cGMP is superior to prostaglandin e1 for lung preservation
Ann. Thorac. Surg., October 1, 1999; 68(4): 1138 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Massberg, M. Sausbier, P. Klatt, M. Bauer, A. Pfeifer, W. Siess, R. Fassler, P. Ruth, F. Krombach, and F. Hofmann
Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3',5'-Monophosphate Kinase I
J. Exp. Med., April 19, 1999; 189(8): 1255 - 1264.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Massberg, G. Enders, R. Leiderer, S. Eisenmenger, D. Vestweber, F. Krombach, and K. Messmer
Platelet-Endothelial Cell Interactions During Ischemia/Reperfusion: The Role of P-Selectin
Blood, July 15, 1998; 92(2): 507 - 515.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.